Rumored Buzz on cgmp compliance
No. 21 CFR 211.113(a) requires appropriate written strategies to generally be proven and adopted in the course of manufacturing to stop objectionable microorganisms in drug products not necessary to be sterile. Moreover, the 2nd paragraph of USP Standard Chapter Antimicrobial Efficiency Testing reads: Antimicrobial preservatives shouldn't